Medicover AB (publ) (0RPS.L)

SEK 242.0

(0.05%)

Long Term Debt Summary of Medicover AB (publ)

Medicover AB (publ)'s latest annual long term debt in 2023 was 774.6 Million EUR , down -7.58% from previous year.
Medicover AB (publ)'s latest quarterly long term debt in 2024 Q2 was 888 Million EUR , up 13.42% from previous quarter.
Medicover AB (publ) reported annual long term debt of 838.1 Million EUR in 2022, up 24.05% from previous year.
Medicover AB (publ) reported annual long term debt of 675.6 Million EUR in 2021, up 112.52% from previous year.
Medicover AB (publ) reported quarterly long term debt of 888 Million EUR for 2024 Q2, up 13.42% from previous quarter.
Medicover AB (publ) reported quarterly long term debt of 811.2 Million EUR for 2023 Q2, down -0.61% from previous quarter.

Annual Long Term Debt Chart of Medicover AB (publ) (2023 - 2014)

Historical Annual Long Term Debt of Medicover AB (publ) (2023 - 2014)

Year	Long Term Debt	Long Term Debt Growth
2023	774.6 Million EUR	-7.58%
2022	838.1 Million EUR	24.05%
2021	675.6 Million EUR	112.52%
2020	317.9 Million EUR	3.96%
2019	305.8 Million EUR	141.55%
2018	126.6 Million EUR	139.32%
2017	52.9 Million EUR	-72.93%
2016	195.4 Million EUR	54.83%
2015	126.2 Million EUR	31450.0%
2014	400 Thousand EUR	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	828.2 Million EUR	7.43%
2024 Q2	888 Million EUR	13.42%
2023 Q2	811.2 Million EUR	-0.61%
2023 FY	774.6 Million EUR	-7.58%
2023 Q4	774.6 Million EUR	-2.46%
2023 Q1	816.2 Million EUR	-2.61%
2023 Q3	794.1 Million EUR	-2.11%
2022 Q1	703.3 Million EUR	4.1%
2022 Q4	838.1 Million EUR	18.85%
2022 Q3	705.2 Million EUR	-2.15%
2022 Q2	720.7 Million EUR	2.47%
2022 FY	838.1 Million EUR	24.05%
2021 Q1	326.8 Million EUR	2.8%
2021 Q4	675.6 Million EUR	58.82%
2021 Q2	366.4 Million EUR	12.12%
2021 FY	675.6 Million EUR	112.52%
2021 Q3	425.4 Million EUR	16.1%
2020 Q4	317.9 Million EUR	6.53%
2020 Q1	308.4 Million EUR	0.85%
2020 Q2	294.2 Million EUR	-4.6%
2020 Q3	298.4 Million EUR	1.43%
2020 FY	317.9 Million EUR	3.96%
2019 Q2	259.6 Million EUR	2.04%
2019 FY	305.8 Million EUR	141.55%
2019 Q4	305.8 Million EUR	81.27%
2019 Q3	168.7 Million EUR	-35.02%
2019 Q1	254.4 Million EUR	100.95%
2018 Q1	51.4 Million EUR	-2.84%
2018 Q4	126.6 Million EUR	2.84%
2018 Q3	123.1 Million EUR	71.45%
2018 Q2	71.8 Million EUR	39.69%
2018 FY	126.6 Million EUR	139.32%
2017 Q4	52.9 Million EUR	32.58%
2017 FY	52.9 Million EUR	-72.93%
2017 Q1	36.9 Million EUR	-81.12%
2017 Q2	35.7 Million EUR	-3.25%
2017 Q3	39.9 Million EUR	11.76%
2016 Q1	- EUR	0.0%
2016 Q4	195.4 Million EUR	0.0%
2016 FY	195.4 Million EUR	54.83%
2015 FY	126.2 Million EUR	31450.0%
2014 FY	400 Thousand EUR	0.0%

Peer Long Term Debt Comparison of Medicover AB (publ)

Name	Long Term Debt	Long Term Debt Difference
Xvivo Perfusion AB (publ)	21.16 Million SEK	-3559.124%